Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | ![]() LamdaGen Corporation Issued Japan Patent for Enzymatic Diagnostic Assays on Plasmonic NanosensorsPatent for Ultra-Sensitive In-Vitro and POC Diagnostic Technology Platform
“The issuance of this patent underscores LamdaGen’s unique ability to harness the significant potential of modern plasmonics in greatly enhancing the detection sensitivity and speed of current immuno-diagnostics,” The patent claims broadly cover nano-plasmonic surfaces and particles used in various ways as solid supports for high-speed plasmonic ELISA assays. The methods can facilitate detection limits into the femtomolar range, nearly four orders of magnitude lower than that of conventional ELISA assays. About LamdaGen Corporation LamdaGen is a nano-technology platform company providing plasmonic sensors and analytical systems for diagnostic and life science markets. The company’s Localized Surface Plasmon Resonance (LSPR) sensors and systems enable real-time detection of biomolecular interactions, as well as enzymatic and chemical reactions. LamdaGen is a privately held company headquartered in Menlo Park, California and is the first to offer commercial LSPR products. For more information, visit http://www.lamdagen.com Media Contact: Alice F. Huang 650.571.5816 ahuang@lamdagen.com End
|
|